PFAS Settlement Payout Date for Individuals: 2026 Update

PFAS Settlement Payout Date for Individuals: No Personal Injury Deal or Trial Date as of September 2026

Updated September 29, 2026: This post now answers the question most readers arrive with: when individuals will get PFAS settlement money. The 2026 water-system claim deadlines it originally tracked have all passed and are summarized below as history. Case counts, bellwether dates, and state settlements reflect court orders and company filings available on this date.

No court order or settlement document sets a date for individuals to receive PFAS settlement money. As of September 29, 2026, there is no personal injury settlement in the federal AFFF litigation, MDL 2873, so there is no claims program, claim form, or payment schedule for people with kidney cancer, testicular cancer, thyroid disease, ulcerative colitis, or the other conditions in the case. The multibillion-dollar PFAS settlements in the news pay public water systems and state governments. The docket held 15,264 pending actions on September 1, 2026, the third-largest count of any pending MDL, according to the Judicial Panel on Multidistrict Litigation.

Settlement talks over the personal injury claims are happening, but nothing has been agreed. In its quarterly report filed July 21, 2026, 3M said the parties "continue to participate in court-ordered settlement discussions regarding the personal injury claims" through a court-appointed mediator. Chemours, in its August 5, 2026 filing, said it, DuPont, and Corteva are part of those talks and that "there is no guarantee that the discussions will result in a settlement." No bellwether trial is on the calendar.

Who the Big PFAS Settlements Actually Pay

Every major AFFF settlement so far pays a public entity. 3M's public water system settlement carries a present value of up to $10.3 billion and $10.5 billion to $12.5 billion in total payments, scheduled from 2024 through 2036. DuPont, Chemours, and Corteva contributed $1.185 billion to a water district settlement fund. Tyco Fire Products agreed to pay $750 million on April 12, 2024 and made its final payment in December 2024. A federal judge approved the Tyco deal and a BASF water-system settlement of more than $300 million in November 2024.

The settlement classes in those deals are made up of public water systems. A person who drank contaminated water or handled AFFF on the job is not a class member and cannot file a claim in them.

Two state deals this summer also pay governments. On August 7, 2026, New Jersey announced federal court approval of its settlements with the DuPont entities and 3M, valued together at about $2.5 billion and paid annually over 25 years, including up to $795 million held in trust for PFAS abatement statewide. On September 10, 2026, Chemours, DuPont, and Corteva agreed to pay $455 million over 15 years to North Carolina and 11 local entities, mostly over discharges from the Fayetteville Works plant. That agreement becomes final only after the covered lawsuits are dismissed.

Where Personal Injury Claims Stand in MDL 2873

Judge Richard M. Gergel oversees MDL 2873 in the District of South Carolina. Case Management Order 35 names the six conditions plaintiffs' leadership is pursuing: kidney cancer, testicular cancer, ulcerative colitis, thyroid disease, liver cancer, and thyroid cancer.

No Trial Date Since October 2025

The first personal injury bellwether trial was set for October 20, 2025. The court vacated it in CMO 35 on August 15, 2025 after learning of a large number of unfiled cases. According to 3M's filing, that trial would have involved one or more of three kidney cancer plaintiffs, and "No new trial date has been set." None of the case management orders posted on the court's MDL 2873 orders page since then, through CMO 33F on August 31, 2026, sets one.

Group B Bellwether Deadlines Moved to November 20

Group B covers thyroid disease and ulcerative colitis. It includes two thyroid disease plaintiffs and one ulcerative colitis plaintiff already approved for expert discovery, plus three more ulcerative colitis plaintiffs, of whom the parties will propose which move forward. Fact discovery for the group ended in March 2026 under CMO 26N. The parties were due to pick the ulcerative colitis cases and propose an expert schedule by July 20, 2026, but CMO 26O, entered July 30, 2026, moved both deadlines to November 20, 2026.

Thyroid Cancer and Liver Cancer Expert Challenges Run Into 2027

The parties finished general causation expert discovery for thyroid cancer and liver cancer in April 2026, 3M reported. Under CMO 33F, entered August 31, 2026, Rule 702 motions on those experts were due August 26, 2026, responses are due November 20, 2026, and replies are due January 22, 2027. The court said it will advise the parties later on any hearing. Those rulings will affect whether thyroid cancer and liver cancer claims can move forward on general causation.

The Court Is Clearing the Docket First

Much of the court's recent work has gone into sorting out who belongs in the MDL. Under CMO 37, defendants moved to dismiss thousands of plaintiffs for missing fact sheets, diagnosis records, or exposure documentation, and the court appointed a special master in June 2026 to handle those motions. CMO 38, entered June 3, 2026, addresses plaintiffs who filed more than one personal injury case, often through different law firms. After the portal administrator sends notice, counsel have 30 days to confer and 60 days to dismiss the extra filings so that each plaintiff keeps one case.

The tier ranges above come from LegalClarity's summary of attorney estimates, which describes them as projections based on the water settlements and comparable mass torts.

Background on AFFF and Personal Injury Claims

Per- and polyfluoroalkyl substances (PFAS) are synthetic fluorinated compounds manufactured since the 1940s. Their carbon-fluorine bonds keep them from breaking down in the environment. EPA monitoring data analyzed by EWG shows 165 million Americans live in areas with measurable PFAS in municipal water, with contamination found in all 50 states.

Personal injury claims largely stem from aqueous film-forming foam (AFFF), a firefighting agent used heavily by the Department of Defense, airports, and industrial facilities. Runoff from fire training sites reached groundwater. The International Agency for Research on Cancer classified occupational exposure as a firefighter as a Group 1 human carcinogen in 2022, and occupational studies show elevated serum PFAS concentrations in exposed personnel.

History: The 2026 Water-System Claim Deadlines

This post first tracked three Phase 2 filing deadlines for water systems in the 3M and DuPont settlements. All three have passed. Per the National League of Cities:

• March 31, 2026: Testing Claims, for reimbursement of eligible PFAS testing costs
• July 31, 2026: Action Fund Claims, the primary claims submission deadline
• August 1, 2026: Special Needs Fund Claims, for systems with costs to manage PFAS

3M's filing confirms that class members seeking compensation based on their PFAS testing results had to submit them by July 31, 2026. These deadlines applied only to public water systems. They never governed individual claims.

Evidentiary and Medical Record Complexity

PFAS claims involve decades between exposure and diagnosis, and that gap drives most of the records work.

A claimant diagnosed with renal cell carcinoma in 2024 often needs military service records from the 1990s, occupational exposure logs, baseline blood panel histories, and pathology reports from several regional medical centers. Firms that retrieve and verify those records early can tier claims accurately before any settlement sets the criteria.

Federal Regulatory Standards

The EPA confirmed it will keep National Primary Drinking Water Regulations for PFOA and PFOS at 4 parts per trillion. Under a proposed rule announced May 18, 2026, water systems could request two more years, to 2031, to comply. The comment period closed July 20, 2026, and the rule remains a proposal. A separate proposal would rescind the regulations for PFHxS, PFNA, GenX chemicals, and the hazard index mixture that includes PFBS.

For litigation, legacy PFOA and PFOS claims keep strong regulatory support, while claims tied to replacement chemistries need their own exposure modeling.

A Second PFAS Docket Is Now Live

On August 18, 2026, the JPML centralized firefighter turnout gear PFAS claims as MDL 3191 in the District of Minnesota before Judge Jeffrey M. Bryan, rejecting a merger into MDL 2873. The new MDL had 8 actions pending on September 1, 2026. Turnout gear claims allege direct skin exposure through protective clothing rather than water contamination, so they carry separate proof requirements. Firefighters with both exposure pathways face a decision about which docket fits their facts.

Dates to Watch

Preparing PFAS Inventories While Talks Continue

With no trial date and settlement talks still open, litigation teams are auditing PFAS inventories to confirm proof of exposure and diagnosis. When a settlement does come, its eligibility rules will decide which claims qualify and at what tier, and files with verified oncology reports, serum lab records, and complete provider histories will be ready to meet them. LlamaLab assembles those files at mass tort scale, across military, VA, and civilian providers, in 4 days on average.

Because medical record retrieval cost is a dedicated case expense, itemized per-case invoices flow directly onto settlement statements upon resolution. How that billing model compares across vendors is covered in LlamaLab's overview of medical record retrieval services for mass tort and PI firms.

Preparing PFAS files while talks continue?

Get the retrieval checklist, the follow-up cadence, and a mass tort intake workflow that holds up at docket scale.

Get the playbookFree PDF, 16 pages

This article is for informational purposes only and does not constitute legal or medical advice. Consult with qualified professionals for advice specific to your situation.

Sources: JPML pending MDL report, September 1, 2026, MDL 2873 orders page including CMO 35, CMO 26N, CMO 26O, CMO 33F, and CMO 38, 3M Form 10-Q, July 2026, 3M public water supplier settlement release, Chemours Form 10-Q, August 2026, Chemours North Carolina settlement release (SEC exhibit), Johnson Controls Form 10-Q, July 2026, New Jersey Attorney General, National League of Cities, Drugwatch, LegalClarity, AFFF payout estimates, EPA, Environmental Working Group, PMC, PubMed, HarrisMartin, MDL 3191 order.